Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

Por Hulshoff, J. B., Faiz, Z., Karrenbeld, A., Kats-Ugurlu, G., Burgerhof, J. G. M., Smit, J. K., Plukker, J. Th. M.
Publicado no Ann Surg Oncol (2015)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?

Por Herrera, Luis J.
Publicado em 2009

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma

Por Verhage, Roy J. J., van der Horst, Sylvia, van der Sluis, Pieter C., Lolkema, Martijn P. J. K., van Hillegersberg, Richard
Publicado em 2011

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Por Schreurs, L. M. A., Janssens, A. C. J. W., Groen, H., Fockens, P., van Dullemen, H. M., van Berge Henegouwen, M. I., Sloof, G. W., Pruim, J., van Lanschot, J. J. B., Steyerberg, E. W., Plukker, J. Th. M.
Publicado no Ann Surg Oncol (2011)

Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer

Por van der Sluis, P. C., Ruurda, J. P., Verhage, R. J. J., van der Horst, S., Haverkamp, L., Siersema, P. D., Borel Rinkes, I. H. M., ten Kate, F. J. W., van Hillegersberg, R.
Publicado no Ann Surg Oncol (2015)

Treatment and Survival Differences in Older Medicare Patients With Lung Cancer as Compared With Those Who Are Dually Eligible for Medicare and Medicaid

Por Bradley, Cathy J., Dahman, Bassam, Given, Charles W.
Publicado em 2008

Impact of Endoscopic Ultrasonography on (18)F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment

Por Hulshoff, J. B., Mul, V. E. M., de Boer, H. E. M., Noordzij, W., Korteweg, T., van Dullemen, H. M., Nagengast, W. B., Oppedijk, V., Pierie, J. P. E. N., Plukker, John Th. M.
Publicado no Ann Surg Oncol (2017)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer

Por Visser, E., Leeftink, A. G., van Rossum, P. S. N., Siesling, S., van Hillegersberg, R., Ruurda, J. P.
Publicado no Ann Surg Oncol (2016)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent

Por Parry, K., Visser, E., van Rossum, P. S. N., Mohammad, N. Haj, Ruurda, J. P., van Hillegersberg, R.
Publicado no Ann Surg Oncol (2015)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

Por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2012

Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera

Por Qiu, Ji, Choi, Gina, Li, Lin, Wang, Hong, Pitteri, Sharon J., Pereira-Faca, Sandra R., Krasnoselsky, Alexei L., Randolph, Timothy W., Omenn, Gilbert S., Edelstein, Cim, Barnett, Matt J., Thornquist, Mark D., Goodman, Gary E., Brenner, Dean E., Feng, Ziding, Hanash, Samir M.
Publicado em 2008

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer

Por Talsma, Koen, van Hagen, Pieter, Grotenhuis, Brechtje A., Steyerberg, Ewout W., Tilanus, Hugo W., van Lanschot, Jan J. B., Wijnhoven, Bas P. L.
Publicado em 2012

Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non–Small-Cell Lung Cancer

Por Heist, Rebecca Suk, Zhou, Wei, Wang, Zhaoxi, Liu, Geoffrey, Neuberg, Donna, Su, Li, Asomaning, Kofi, Hollis, Bruce W., Lynch, Thomas J., Wain, John C., Giovannucci, Edward, Christiani, David C.
Publicado em 2008

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North...

Por Strauss, Gary M., Herndon, James E., Maddaus, Michael A., Johnstone, David W., Johnson, Elizabeth A., Harpole, David H., Gillenwater, Heidi H., Watson, Dorothy M., Sugarbaker, David J., Schilsky, Richard L., Vokes, Everett E., Green, Mark R.
Publicado em 2008

Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non–Small-Cell Lung Cancer

Por Riely, Gregory J., Rizvi, Naiyer A., Kris, Mark G., Milton, Daniel T., Solit, David B., Rosen, Neal, Senturk, Emir, Azzoli, Christopher G., Brahmer, Julie R., Sirotnak, Francis M., Seshan, Venkatraman E., Fogle, Margaret, Ginsberg, Michelle, Miller, Vincent A., Rudin, Charles M.
Publicado em 2009

Current and Evolving Surgical Strategies in Thoracic Oncology

Por Harish, K.
Publicado em 2013

Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline

Por Rodrigues, George, Videtic, Gregory M.M., Sur, Ranjan, Bezjak, Andrea, Bradley, Jeffrey, Hahn, Carol A., Langer, Corey, Miller, Keith L., Moeller, Benjamin J., Rosenzweig, Kenneth, Movsas, Benjamin
Publicado em 2011

Reducing Persistent Postoperative Pain and Disability 1 Year After Breast Cancer Surgery: A Randomized, Controlled Trial Comparing Thoracic Paravertebral Block to Local Anesthetic Infiltration

Por Chiu, Michelle, Bryson, Gregory L., Lui, Anne, Watters, James M., Taljaard, Monica, Nathan, Howard J.
Publicado em 2013

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

Por Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
Publicado no Am J Clin Oncol (2016)

Patient Education Level As a Predictor of Survival In Lung Cancer Clinical Trials

Por Herndon, James E., Kornblith, Alice B., Holland, Jimmie C., Paskett, Electra D.
Publicado em 2008